GAVILAX
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
17856-0312 -
Package NDC
17856-0312-1 -
Package NDC
17856-0312-2 -
Package NDC
17856-0312-3 -
Package NDC
17856-0312-4 -
Package NDC
17856-0312-5 -
Package NDC
17856-0312-6 -
Package NDC
17856-0312-7 -
Package NDC
17856-0312-8 -
Package NDC
17856-0312-9 -
Application number
ANDA091077 -
SPL ID
3a86670e-4e74-3a85-e063-6394a90ad435 -
SPL set ID
c9688f06-b6db-4afb-b8ff-ef5fb8bf9946 -
UNII
G2M7P15E5P -
RxCUI
876193 -
RxCUI
876214
What the source publishes
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Active ingredients
- Polyethylene Glycol 3350
- Form
- POWDER, FOR SOLUTION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN OTC DRUG
- Prescription
- Non-prescription
Names this record is found by
Complete source data
{
"name": "GAVILAX",
"splId": "3a86670e-4e74-3a85-e063-6394a90ad435",
"labels": [
{
"setId": "c9688f06-b6db-4afb-b8ff-ef5fb8bf9946",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c9688f06-b6db-4afb-b8ff-ef5fb8bf9946",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c9688f06-b6db-4afb-b8ff-ef5fb8bf9946"
}
],
"routes": [
"ORAL"
],
"labeler": "ATLANTIC BIOLOGICALS CORP.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "17 g in 1 BAG (17856-0312-1)",
"package_ndc": "17856-0312-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20210126"
},
{
"sample": false,
"description": "8.5 g in 1 BAG (17856-0312-2)",
"package_ndc": "17856-0312-2",
"identifierStatus": "well-formed",
"marketing_start_date": "20210126"
},
{
"sample": false,
"description": "17 g in 1 CUP (17856-0312-3)",
"package_ndc": "17856-0312-3",
"identifierStatus": "well-formed",
"marketing_start_date": "20210126"
},
{
"sample": false,
"description": "4 g in 1 BAG (17856-0312-4)",
"package_ndc": "17856-0312-4",
"identifierStatus": "well-formed",
"marketing_start_date": "20210126"
},
{
"sample": false,
"description": "50 CUP in 1 CASE (17856-0312-5) / 8.5 g in 1 CUP",
"package_ndc": "17856-0312-5",
"identifierStatus": "well-formed",
"marketing_start_date": "20210126"
},
{
"sample": false,
"description": "72 POUCH in 1 CASE (17856-0312-6) / 4.5 g in 1 POUCH",
"package_ndc": "17856-0312-6",
"identifierStatus": "well-formed",
"marketing_start_date": "20210126"
},
{
"sample": false,
"description": "50 BAG in 1 BOX, UNIT-DOSE (17856-0312-7) / 4.25 g in 1 BAG",
"package_ndc": "17856-0312-7",
"identifierStatus": "well-formed",
"marketing_start_date": "20231010"
},
{
"sample": false,
"description": "72 BAG in 1 BOX, UNIT-DOSE (17856-0312-8) / 4.25 g in 1 BAG",
"package_ndc": "17856-0312-8",
"identifierStatus": "well-formed",
"marketing_start_date": "20250722"
},
{
"sample": false,
"description": "50 CUP in 1 BOX, UNIT-DOSE (17856-0312-9) / 4.25 g in 1 CUP",
"package_ndc": "17856-0312-9",
"identifierStatus": "well-formed",
"marketing_start_date": "20250722"
}
],
"productId": "17856-0312_3a86670e-4e74-3a85-e063-6394a90ad435",
"useDomain": "unknown",
"dosageForm": "POWDER, FOR SOLUTION",
"productNdc": "17856-0312",
"deaSchedule": null,
"genericName": "Polyethylene Glycol 3350",
"productType": "HUMAN OTC DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "POLYETHYLENE GLYCOL 3350",
"strength": "17 g/17g"
}
],
"applicationNumber": "ANDA091077",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20210126",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "non-prescription",
"harmonizedIdentifiers": {
"nui": [
"N0000010288",
"N0000175811",
"N0000009871"
],
"unii": [
"G2M7P15E5P"
],
"rxcui": [
"876193",
"876214"
],
"spl_set_id": [
"c9688f06-b6db-4afb-b8ff-ef5fb8bf9946"
],
"pharm_class_pe": [
"Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"
],
"pharm_class_epc": [
"Osmotic Laxative [EPC]"
],
"pharm_class_moa": [
"Osmotic Activity [MoA]"
],
"manufacturer_name": [
"ATLANTIC BIOLOGICALS CORP."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:17856-0312_3a86670e-4e74-3a85-e063-6394a90ad435"